Related Experiment Videos
Endoscopic therapy of biliary and pancreatic disorders in children
1Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas.
Insights
Therapeutic endoscopic retrograde cholangiopancreatography (ERCP) is safe and effective for pediatric patients with pancreaticobiliary conditions. Experienced endoscopists can successfully perform these specialized procedures with minimal complications.
Area of Science:
- Pediatric Gastroenterology
- Interventional Endoscopy
- Biliary and Pancreatic Diseases
Background:
- Limited data exists on therapeutic endoscopic retrograde cholangiopancreatography (ERCP) in pediatric populations.
- Pancreaticobiliary pathologies in children often require specialized interventions.
Purpose of the Study:
- To evaluate the safety and efficacy of therapeutic ERCP in pediatric patients.
- To analyze the outcomes of various therapeutic interventions for pancreaticobiliary conditions in children.
Main Methods:
- A retrospective review of 42 ERCP procedures performed on 25 pediatric patients (ages 22 months to 19 years).
- Procedures included sphincterotomy, dilation, and stent placement for various pancreaticobiliary indications.
- Data collection focused on procedural success, therapeutic interventions, and complications.
Main Results:
- Five patients had normal findings; the rest presented with pancreaticobiliary anomalies.
- Therapeutic interventions were performed in 17 patients, including sphincterotomy (n=12), dilation (n=6), and stent placement (n=9).
- Minor complications (abdominal pain, vomiting) occurred in 5 patients; no major technical or medical complications were observed.
Conclusions:
- Therapeutic ERCP is a safe and feasible treatment option for pediatric patients with pancreaticobiliary diseases.
- Successful outcomes are dependent on the expertise of highly experienced endoscopists skilled in pediatric procedures.
Abstract:
Although many reports in the literature describe the use of endoscopic retrograde cholangiopancreatography (ERCP) in children, few mention the therapeutic application of the technique in treating pediatric patients with pancreatic or biliary pathology. We report here on our two-year experience, consisting of 42 ERCPs conducted in 25 patients for a variety of pancreaticobiliary indications. Ages ranged from 22 months to 19 years. Five patients had normal studies; the remainder were diagnosed with a variety of pancreatic and or biliary anomalies. Seventeen patients had therapeutic interventions consisting of sphincterotomy (n = 12), dilation (n = 6), or stent placement (n = 9), with many of these procedures being done in combination. Five patients had mild complaints of abdominal pain or vomiting immediately after ERCP, but no major technical or medical complications were encountered. We find that therapeutic ERCP can be safely performed in children, but only by highly experienced endoscopists familiar with these specialized procedures.